electroCore Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4)

ECOR 11.08.2024

Full Press ReleaseSEC FilingsOur ECOR Tweets

About Gravity Analytica

Recent News

  • 01.07.2025 - electroCore Expands Intellectual Property Portfolio
  • 12.17.2024 - electroCore to Acquire NeuroMetrix, Gaining Access to its Quell Platform and Positioning Itself as a Significant Player in Non-Invasive Bioelectronic Medicine and Wellness
  • 11.20.2024 - electroCore’s Truvaga™ Plus Wins Woman’s World Magazine 50 over 50 Award

Recent Filings

  • 01.21.2025 - 4 Statement of changes in beneficial ownership of securities
  • 01.17.2025 - EX-99.1 EX-99.1
  • 01.17.2025 - 8-K Current report

ROCKAWAY, N.J.,Nov. 08, 2024(GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced thatThomas Freeburgwill join electroCore, effectiveNovember 11, 2024, as the Company’s VP, Corporate Controller. The Compensation Committee of electroCore’s Board of Directors granted 5,000 restricted stock units (“RSUs”) toMr. Freeburgin connection with the commencement of his employment. The RSUs were granted as an inducement material to Mr. Freeburg’s commencement of employment pursuant to NASDAQ Listing Rule 5635(c)(4). 33% of the RSUs will vest on each of the first, second and third anniversaries of the date of grant, subject to Mr. Freeburg’s continued employment by the Company on the applicable vesting date. Upon vesting, the RSUs shall be settled in shares of the Company’s common stock.

About electroCore, Inc.

electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company dedicated to improving health and promoting general wellness through its non-invasive vagus nerve stimulation (“nVNS”) technology platform. The company’s is focused on the commercialization of medical devices for the management and treatment of certain medical conditions and consumer product offerings utilizing nVNS to promote general wellbeing and human performance inthe United Statesand select overseas markets.

For more information, visitwww.electrocore.com.

Contact:ECOR Investor Relations(973) 302-9253investors@electrocore.com

Primary Logo

Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com